Some 27% fewer new pharmaceutical active ingredients (i.e. new single-source brands) were launched in the European reference markets under the GLOBE and GUARD MFN Medicare demonstration models in the 17 months after President Donald Trump published his Most Favored Nation (MFN) executive order (EO), compared to the prior 17-month period, according to the latest analysis […]